Ascend Vitality review

The semaglutide page advertises $199 for a monthly plan versus $297 for the first three months. Tirzepatide shows $249 monthly versus $447 initially. The lower monthly equivalents are introductory three-month offers. Confirm the next renewal charge and whether the medication supply ships together or in separate deliveries; a monthly equivalent does not establish shipment timing.

Its product pages advertise no membership fee and include evaluation, provider messaging, dose adjustments and shipping. The AV15 promotion is separate advertising; do not assume it combines with the introductory offer. Ask for the complete selected-plan total, including any required labs, before payment.

The product pages promote medication, labs and care together, while the terms permit separate laboratory charges unless explicitly included in the selected program. They also allow clinically required testing. Confirm the required panel, its payer and any repeat-testing charge in writing.

The January 2026 terms require cancellation at least five business days before the scheduled charge through the available portal or account email. A later request can leave the next period payable. Cancellation stops later renewals and does not retroactively refund previous charges; pausing is discretionary.

The homepage says payment depends on a prescription, but the terms allow charges for evaluation and processing even when no prescription results. They do not promise a refund for side effects, dissatisfaction or unused treatment. Ask which charges survive clinical decline or a medically required stop before authorizing services.

Dispensed or shipped prescriptions cannot be returned under the terms. For confirmed loss or material damage, Ascend may investigate and coordinate a replacement or another resolution, potentially requiring photos and pharmacy or carrier review. That discretionary process is not a general money-back guarantee.